28 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks? https://www.fool.com/investing/2019/09/05/how-will-johnson-johnsons-opioid-case-ruling-impac.aspx?source=iedfolrf0000001 Sep 05, 2019 - Investors need to be careful about which pharmaceutical stocks they own.
Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease http://www.zacks.com/stock/news/503280/endo-gains-fda-nod-for-orfadin-generic-to-treat-rare-disease?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-503280 Sep 05, 2019 - Endo (ENDP) receives an FDA approval for the generic equivalent of Swedish Orphan Biovitrum's Orfadin.
ETFs Poised to Benefit from Gene Editing Revolution http://www.zacks.com/stock/news/505549/etfs-poised-to-benefit-from-gene-editing-revolution?cid=CS-ZC-FT-etf_news_and_commentary-505549 Sep 06, 2019 - Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.
Allergan's Filings for Abicipar Pegol Accepted in U.S/Europe http://www.zacks.com/stock/news/512573/allergans-filings-for-abicipar-pegol-accepted-in-us-europe?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-512573 Sep 11, 2019 - The FDA is expected to give its decision on Allergan's (AGN) BLA for its anti-VEGF product, abicipar pegol in mid-2020, while the EMA's decision is expected in the second half of 2020.
Pharma Stock Roundup: Pipeline/Regulatory Updates From GSK, PFE & Others http://www.zacks.com/stock/news/516828/pharma-stock-roundup-pipeline-regulatory-updates-from-gsk-pfe-others?cid=CS-ZC-FT-analyst_blog|stock_roundup-516828 Sep 13, 2019 - Glaxo's (GSK) Nucala gets FDA nod for use in kids. Pfizer (PFE), Allergan (AGN) & Roche (RHHBY) give regular pipeline/regulatory updates.
Top Analyst Reports for Bristol-Myers Squibb, Lockheed Martin & Alphabet http://www.zacks.com/research-daily/531879/top-analyst-reports-for-bristol-myers-squibb-lockheed-martin-alphabet?cid=CS-ZC-FT-research_daily-531879 Sep 23, 2019 - Top Analyst Reports for Bristol-Myers Squibb, Lockheed Martin & Alphabet
Editas Inks Deal for Gene Editing Neurological Disease Drugs http://www.zacks.com/stock/news/567847/editas-inks-deal-for-gene-editing-neurological-disease-drugs?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-567847 Oct 16, 2019 - Editas (EDIT) and privately held Asklepios BioPharmaceutical will collaborate on exploring in vivo delivery of genome editing medicines to treat neurological diseases.
J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos http://www.zacks.com/stock/news/575752/jj-jnj-recalls-baby-powder-batch-as-fda-finds-asbestos?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-575752 Oct 21, 2019 - J&J (JNJ) voluntarily recalls one lot of its baby powders, which is the subject of numerous lawsuits claiming that its talc-based products contain asbestos that causes cancer.
Allergan (AGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release http://www.zacks.com/stock/news/590606/allergan-agn-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q3-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-590606 Oct 29, 2019 - Allergan (AGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Festival honors former Quiksilver CEO Pierre Agnes, lost at sea in 2018 https://www.ocregister.com/2019/10/29/festival-honors-former-quiksilver-ceo-pierre-agnes-lost-at-sea-in-2018/ Oct 29, 2019 - Agnes disappeared during a storm while sailing off the coast of his native France.

Pages: 123

Page 1>